AAAAAA

   
Results: 1-19 |
Results: 19

Authors: CHRISTENSON RH DUH SH NEWBY LK OHMAN EM CALIFF RM GRANGER CB PECK S PIEPER KS ARMSTRONG PW KATUS HA TOPOL EJ
Citation: Rh. Christenson et al., CARDIAC TROPONIN-T AND CARDIAC TROPONIN-I - RELATIVE VALUES IN SHORT-TERM RISK STRATIFICATION OF PATIENTS WITH ACUTE CORONARY SYNDROMES, Clinical chemistry, 44(3), 1998, pp. 494-501

Authors: NEWBY LK CHRISTENSON RH OHMAN EM ARMSTRONG PW THOMPSON TD LEE KL HAMM CW KATUS HA CIANCIOLO C GRANGER CB TOPOL EJ CALIFF RM
Citation: Lk. Newby et al., VALUE OF SERIAL TROPONIN-T MEASURES FOR EARLY AND LATE RISK STRATIFICATION IN PATIENTS WITH ACUTE CORONARY SYNDROMES, Circulation, 98(18), 1998, pp. 1853-1859

Authors: ALEXANDER JH SPARAPANI RA MAHAFFEY KW NEWBY LK BERDAN LG HARRINGTON RA
Citation: Jh. Alexander et al., LONG-TERM MORTALITY INCREASES DRAMATICALLY IN ACUTE CORONARY SYNDROMEPATIENTS WITH MULTIPLE RECURRENT MYOCARDIAL INFARCTIONS WITHIN 30 DAYS, Circulation, 98(17), 1998, pp. 2928-2928

Authors: ALEXANDER JH SPARAPANI RA MAHAFFEY KW NEWBY LK BERDAN LG SIMOONS ML HARRINGTON RA
Citation: Jh. Alexander et al., 30-DAY AND 6-MONTH MORTALITY IS PROPORTIONAL TO MAGNITUDE OF PEAK CREATINE-KINASE ELEVATION IN THE NON-ST-ELEVATION ACUTE CORONARY SYNDROMES, Circulation, 98(17), 1998, pp. 3306-3306

Authors: NEWBY LK EISENSTEIN EL CALIFF RM THOMPSON TD NELSON CL PETERSON ED MARK DB
Citation: Lk. Newby et al., HOSPITAL STAYS PAST 72 HOURS IN UNCOMPLICATED ACUTE MYOCARDIAL-INFARCTION PATIENTS ARE NOT COST-EFFECTIVE, Circulation, 98(17), 1998, pp. 3952-3952

Authors: ALEXANDER JH NEWBY LK MOLITERNO DJ BHAPKAR M VANDEWERF F WHITE HD HARRINGTON RA TOPOL EJ CALIFF RM
Citation: Jh. Alexander et al., RELATIONSHIP OF OUTCOMES TO TREATMENT WITH LAMIFIBAN IN PATIENTS UNDERGOING PTCA - ANALYSIS OF PARAGON-A, Journal of the American College of Cardiology, 29(2), 1997, pp. 3334-3334

Authors: HARRINGTON RA NEWBY LK MOLITERNO DJ BHAPKAR M ARMSTRONG PW SIMES RJ WHITE HD VANDEWERF F RAMES A TOPOL EJ CALIFF RM
Citation: Ra. Harrington et al., COMBINING IIB IIIA INHIBITION AND HEPARIN FOR ACUTE CORONARY SYNDROMES - EVIDENCE OF A GRADIENT FOR BLEEDING HAZARD FROM THE PARAGON RANDOMIZED FACTORIALLY DESIGNED TRIAL/, Journal of the American College of Cardiology, 29(2), 1997, pp. 3338-3338

Authors: NEWBY LK OHMAN EM GRANGER BB SAWYER T SEDOR F HOLLEMAN CM CALIFF RM
Citation: Lk. Newby et al., USE OF DIAGNOSTIC-TOOLS IN A CHEST PAIN EVALUATION UNIT - VALUE OF TROPONIN-T TESTING, Journal of the American College of Cardiology, 29(2), 1997, pp. 7562-7562

Authors: CHRISTENSON RH OHMAN EM CALIFF RM ARMSTRONG PW NEWBY LK KATUS H PECK S DUH SH TOPOL EJ
Citation: Rh. Christenson et al., CARDIAC TROPONIN-T AND CARDIAC TROPONIN-I COMPARED IN 755 ACUTE CORONARY SYNDROME PATIENTS, Clinical chemistry, 43, 1997, pp. 57-57

Authors: CHRISTENSON RH OHMAN EM TOPOL EJ PECK S NEWBY LK DUH SH KEREIAKES DJ WORLEY SJ ALOSOZANA GL WALL TC CALIFF RM
Citation: Rh. Christenson et al., ASSESSMENT OF CORONARY REPERFUSION AFTER THROMBOLYSIS WITH A MODEL COMBINING MYOGLOBIN, CREATINE KINASE-MB, AND CLINICAL-VARIABLES, Circulation, 96(6), 1997, pp. 1776-1782

Authors: NEWBY LK RUTSCH WR CALIFF RM SIMOONS ML AYLWARD PE ARMSTRONG PW WOODLIEF LH LEE KL TOPOL EJ VANDEWERF F
Citation: Lk. Newby et al., TIME FROM SYMPTOM ONSET TO TREATMENT AND OUTCOMES AFTER THROMBOLYTIC THERAPY, Journal of the American College of Cardiology, 27(7), 1996, pp. 1646-1655

Authors: NEWBY LK CALIFF RM GUERCI A WEAVER WD COL J HORGAN JH MARK DB STEBBINS A VANDEWERF F GORE JM TOPOL EJ
Citation: Lk. Newby et al., EARLY DISCHARGE IN THE THROMBOLYTIC ERA - AN ANALYSIS OF CRITERIA FORUNCOMPLICATED INFARCTION FROM THE GLOBAL UTILIZATION OF STREPTOKINASEAND T-PA FOR OCCLUDED CORONARY-ARTERIES (GUSTO) TRIAL, Journal of the American College of Cardiology, 27(3), 1996, pp. 625-632

Authors: EISENSTEIN EL NEWBY LK PILOTE L PETERSON ED
Citation: El. Eisenstein et al., DO REGIONAL DIFFERENCES IN INVASIVE CARDIAC PROCEDURE HATES DRIVE COSTS OF CARE FOR THE ACUTE MYOCARDIAL-INFARCTION PATIENT, Circulation, 94(8), 1996, pp. 2965-2965

Authors: CALIFF RM NEWBY LK
Citation: Rm. Califf et Lk. Newby, HOW MUCH DO WE GAIN BY REDUCING TIME TO REPERFUSION THERAPY, The American journal of cardiology, 78, 1996, pp. 8-15

Authors: FETTERS JK PETERSON ED SHAW LJ NEWBY LK CALIFF RM
Citation: Jk. Fetters et al., SEX-SPECIFIC DIFFERENCES IN CORONARY-ARTERY DISEASE RISK-FACTORS, EVALUATION, AND TREATMENT - HAVE THEY BEEN ADEQUATELY EVALUATED, The American heart journal, 131(4), 1996, pp. 796-813

Authors: NEWBY LK GIBLER WB OHMAN EM CHRISTENSON RH
Citation: Lk. Newby et al., BIOCHEMICAL MARKERS IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION - THE NEED FOR EARLY ASSESSMENT, Clinical chemistry, 41(9), 1995, pp. 1263-1265

Authors: NEWBY LK CALIFF RM
Citation: Lk. Newby et Rm. Califf, REDEFINING UNCOMPLICATED MYOCARDIAL-INFARCTION IN THE THROMBOLYTIC ERA, Circulation, 90(4), 1994, pp. 110-110

Authors: NEWBY LK CALIFF RM
Citation: Lk. Newby et Rm. Califf, REDEFINING UNCOMPLICATED MYOCARDIAL-INFARCTION IN THE THROMBOLYTIC ERA, Circulation, 90(4), 1994, pp. 110-110

Authors: MORISAKI H MORISAKI T NEWBY LK HOLMES EW
Citation: H. Morisaki et al., ALTERNATIVE SPLICING - A MECHANISM FOR PHENOTYPIC RESCUE OF A COMMON INHERITED DEFECT, The Journal of clinical investigation, 91(5), 1993, pp. 2275-2280
Risultati: 1-19 |